FT
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ·Financial Services·Asset Management
$43.07
+0.70%
Mkt Cap $29.38M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$220.80
Range $149.76 – $259.20
Implied Upside
+412.7%
Consensus $220.80 vs current $43.07